Header cover image

U.S. Clinical Research and Equipment Industry Analysis

UpdatedApr 22, 2026
DataAggregated Company Financials
Companies61
  • 7D-0.001%
  • 3M-18.1%
  • 1Y14.0%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 2.8%, with Thermo Fisher Scientific up 2.3%. This means that the industry has gained 18% over the past year. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 22 Apr 2026US$596.7bUS$148.1bUS$14.2b37.5x42.2x4x
Fri, 20 Mar 2026US$541.3bUS$147.8bUS$14.0b35.1x38.6x3.7x
Sun, 15 Feb 2026US$589.2bUS$147.7bUS$13.9b35.2x42.5x4x
Tue, 13 Jan 2026US$700.7bUS$145.8bUS$12.4b36.8x56.7x4.8x
Thu, 11 Dec 2025US$651.8bUS$145.8bUS$12.5b34.6x52.2x4.5x
Sat, 08 Nov 2025US$635.4bUS$145.7bUS$12.2b34.1x52.2x4.4x
Mon, 06 Oct 2025US$634.9bUS$144.3bUS$14.6b31.2x43.6x4.4x
Wed, 03 Sep 2025US$584.9bUS$144.3bUS$14.6b29.1x40.2x4.1x
Fri, 01 Aug 2025US$574.7bUS$143.7bUS$8.8b36.2x65.2x4x
Sun, 29 Jun 2025US$531.7bUS$142.9bUS$9.1b35.7x58.2x3.7x
Tue, 27 May 2025US$494.4bUS$142.8bUS$9.1b31.6x54.4x3.5x
Thu, 24 Apr 2025US$514.8bUS$142.6bUS$10.0b37.3x51.4x3.6x
Sat, 22 Mar 2025US$592.7bUS$143.0bUS$9.9b38.7x59.9x4.1x
Mon, 17 Feb 2025US$619.7bUS$143.3bUS$10.0b34.4x62x4.3x
Wed, 15 Jan 2025US$678.1bUS$142.4bUS$10.2b43.6x66.5x4.8x
Fri, 13 Dec 2024US$672.5bUS$142.4bUS$10.2b45.6x65.8x4.7x
Sun, 10 Nov 2024US$696.6bUS$142.4bUS$10.3b44.3x67.7x4.9x
Tue, 08 Oct 2024US$733.8bUS$141.8bUS$8.5b37.4x86.4x5.2x
Thu, 05 Sep 2024US$734.2bUS$141.8bUS$8.5b37.6x86.4x5.2x
Sat, 03 Aug 2024US$755.1bUS$140.9bUS$11.3b37.3x67.1x5.4x
Mon, 01 Jul 2024US$680.5bUS$141.3bUS$12.2b37.9x55.9x4.8x
Wed, 29 May 2024US$726.8bUS$141.5bUS$12.4b38.7x58.5x5.1x
Fri, 26 Apr 2024US$707.2bUS$141.7bUS$12.8b38.6x55.4x5x
Sun, 24 Mar 2024US$749.2bUS$142.1bUS$12.8b44.7x58.4x5.3x
Tue, 20 Feb 2024US$720.7bUS$142.2bUS$12.5b43.3x57.5x5.1x
Thu, 18 Jan 2024US$675.0bUS$153.8bUS$14.2b35.1x47.6x4.4x
Sat, 16 Dec 2023US$684.6bUS$153.7bUS$14.2b37.1x48.1x4.5x
Mon, 13 Nov 2023US$585.8bUS$153.8bUS$14.0b30.9x42x3.8x
Wed, 11 Oct 2023US$649.2bUS$154.6bUS$11.2b33.4x57.9x4.2x
Fri, 08 Sep 2023US$705.5bUS$154.6bUS$11.2b32x63x4.6x
Sun, 06 Aug 2023US$724.6bUS$154.7bUS$11.3b30.2x64.4x4.7x
Tue, 04 Jul 2023US$691.6bUS$152.4bUS$12.5b29.6x55.3x4.5x
Thu, 01 Jun 2023US$666.2bUS$152.2bUS$12.5b27.2x53.3x4.4x
Sat, 29 Apr 2023US$699.2bUS$152.9bUS$9.4b29.2x74.1x4.6x
Price to Earnings Ratio

74.1x


Total Market Cap: US$699.2bTotal Earnings: US$9.4bTotal Revenue: US$152.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Clinical Research and Equipment Industry Price to Earnings3Y Average 57.2x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 42.3x which is lower than its 3-year average PE of 57.2x.
  • The industry is trading close to its 3-year average PS ratio of 4.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 14% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Comparison

How does U.S. Clinical Research and Equipment compare with similar industries?

US Market1.31%
Healthcare-1.38%
Life Sciences-0.00096%
Clinical Research and Equipment-0.00096%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TEM Tempus AIUS$55.1511.3%
+US$1.0b
27.6%PS7.8x
WST West Pharmaceutical ServicesUS$274.722.5%
+US$489.0m
27.7%PE40.1x
A Agilent TechnologiesUS$122.091.4%
+US$480.4m
18.8%PE26.7x
WAT WatersUS$335.231.3%
+US$417.2m
1.4%PE51.2x
BIO Bio-Rad LaboratoriesUS$305.674.6%
+US$362.8m
24.8%PE10.9x

Latest News